Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma

British Journal of Ophthalmology

Volumn 82, Issue 7, 1998, Pages 758-762

  Schmidt, Karl Georg ^a,c   Von Rückmann, Andrea ^a   Pillunat, Lutz E ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EYE BLOOD FLOW; EYE PULSE; FEMALE; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0031818366     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.7.758     Document Type: Article

References (49)

1. Schmidt KG, Stegmann DY, Serie JB, et al. Ocular pulse amplitude (OPA) in primary open angle glaucoma, low tension glaucoma, and in ocular hypertensive patients before and after topical drug treatment. Invest Ophthalmol Vis Sci 1991;32(Suppl):943.
2. Schmidt KG, v Rückmann A, Mittag TW. Okuläre Pulsamplitude bei okulärer Hypertension und verschiedenen Glaukomformen. Ophthalmologica 1998;212:5-10.
3. Schmidt KG, Mittag TW, Pavlovic S, et al. Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefes Arch Clin Exp Ophthalmol 1996;234:527-32.
4. Schmidt KG, v Rückmann A, Mittag TW, et al. Reduced ocular pulse amplitude in low tension glaucoma is independent of vasospasm. Eye 1997;11:485-8.
5. Kitazawa Y, Shirai H, Go FJ. The effect of a Ca++ antagonist on visual field in low tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989;227:408-12.
6. Langham ME, To'Mey KF. A clinical procedure for the measurements of the ocular pulse-pressure relationship and ophthalmic arterial pressure. Exp Eye Res 1978;27:17-25.
7. Silver DM, Farrell RA. Validity of pulsatile ocular blood flow measurements. Surv Ophthalmol 1994;38(Suppl):72-80.
8. Aim A. Physiologie der okulären Durchblutung. In: Stodtmeister R, Christ T, Pillunat LE, Ulrich WD, eds. Okuläre Durchblutungsstörungen. 1st ed. Stuttgart: Enke, 1987:9-17.
9. Williamson TH, Harris A. Ocular blood flow measurement. Br J Ophthalmol 1994;78:939-45.
10. Butt Z. Reproducibility of pulsatile ocular blood flow measurement. J Glaucoma 1995;4:214-8.
11. Chidlow G. The ocular blood flow tonometer: a new instrument for the measurement of intraocular pressure. Exp Eye Res 1996;63:463-9.
12. Gambhir S, Inao S, Todokoro M, et al. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography. Neurol Res 1997;19:139-44.
13. Nighoghossian N, Berthezene Y, Meyer R, et al. Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging. J Neurol Sci 1997;149: 171-6.
14. Hayashida K, Tanaka Y, Hirose Y, et al. Vasoreactive effect of azetazolamide as a function of time with sequential PET 150-water measurement. Nucl Med Commun 1996;17: 1047-51.
15. Langham ME, McHenry M. The prevention of visual loss by ocular hypotensive drugs. Invest Ophthalmol Vis Sci 1995;36(Suppl):966.
16. Pfeiffer N. The potential for topical carbonic anhydrase inhibitors in glaucoma therapy. Curr Opin Ophthalmol 1994;5:20-5.
17. Mittag TW, Serle J, Schumer R, et al. Studies of the ocular pulse in primates. Surv Ophthalmol 1994;38(Suppl):183-90.
18. Lippa EA, von Deffner HA, Hoffmann HM, et al. Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor. Arch Ophthalmol 1988;106:1694-6.
19. Pfeiffer N, Hennekes R, Lippa EA, et al. A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients. Br J Ophthalmol 1990;74:405-8.
20. Higginbotham EJ, Kass MA, Lippa EA, et al. MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action. Arch Ophthalmol 1990;108:65-8.
21. Serle JB, Lustgarten JS, Lippa EA, et al. MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility. Arch Ophthalmol 1990;108:838-41.
22. Lippa EA, Aasved H, Airaksinen PJ, et al. Multiple dose, dose response relationship for the topical carbonic anhydrase inhibitor MK-927. Arch Ophthalmol 1991;109: 46-9.
23. Wang RF, Serle JB, Podos SM, et al. MK-507 (L-671, 152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297-9.
24. Kiel JW, Shepard AP. Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci 1992;33:2399-410.
25. Kiel JW. Choroidal myogenic autoregulation and intraocular pressure. Exp Eye Res 1994;58:529-43.
26. Trew DR, Smith SE. Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma. Br J Ophthalmol 1991;75:71-5.
27. Boles-Carenini A, Sibour G, Boles-Carenini B. Differences in the long-term effect of timolol and betaxolol on the pulsatile ocular blood flow. Surv Ophthalmol 1994;8(Suppl): 118-24.
28. Martin XD, Rabineau PA. Vasoconstrictive effect of topical timolol on human retinal arteries. Graefes Arch Clin Exp Ophthalmol 1989;227:526-30.
29. Hartenbaum D. The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension. Clin Ther 1996;18:460-5.
30. Heijl A, Strahlman E, Sverrisson T, et al. A comparison dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. Ophthalmology 1997; 104:137-42.
31. Van Burskirk EM. The ciliary vasculature and its pertubation with drugs and surgery. Trans Am Ophthalmol Soc 1988;86:794-841.
32. Neufeld AH, Sears ML. Adenosine 3′5′-monophosphate increases the outflow of aqueous humor from the rabbit eye. Invest Ophthalmol Vis Sci 1981;20:371-81.
33. Sears ML. Autonomie nervous systemradrenergic agonists. In: Sears ML, ed. Handbook of experimental pharmacology. vol 69. Berlin: Springer, 1984.
34. Townsend DJ, Brubacker RF. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorometry. Invest Ophthalmol Vis Sci 1980;19:256-66.
35. Nagataki S, Brubacker RF. Early effect of epinephrine on aqueous formation in the normal human eye. Invest Ophthalmol 1981;88:278-82.
36. Grunwald JE, Riva CE, Stone RA, et al. Retinal autoregulation in open-angle glaucoma. Ophthalmology 1984;91: 1690-4.
37. Quigley HA, Hohmann RM, Sanchez R, et al. Optic nerve head blood flow in chronic experimental glaucoma. Arch Ophthalmol 1985;103:956-62.
38. Pillunat LE, Stodtmeister R, Marquardt R, et al. Ocular perfusion pressures in different types of glaucoma. Int Ophthalmol 1989;13:37-42.
39. Harris A, Sergott, RC, Spaeth GL, et al. Color doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol 1994;118:642-9.
40. Rojanapongpun P, Drance SM, Morrison BJ. Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br J Ophthalmol 1993;77:25-9.
41. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low tension and open-angle glaucoma. Am J Ophthalmol 1993;115:608-13.
42. Shrier I, Magder S. Effects of nifedipine on vascular water-fall and arterial resistance in canine hindlimb. Am J Physiol 1995;268:371-6.
43. Nyborg NCB, Prieto D, Benedito S, et al. Endothelin-1 induced contraction of bovine retinal small arteries is reversible and abolished by nitrendipine. Invest Ophthalmol Vis Sci 1991;32:27-31.
44. Harada K, Miwa A, Yokoyama T, et al. Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig. Gen Pharmacol 1994;24:935-9.
45. Moriya S, Sugiyama T, Shimizu K, et al. Low-tension glaucoma and endothelin (ET-1). Folia Ophthalmol Jpn 1992;43:554-9.
46. Postiglione A, Bobkiewicz T, Vinholdt-Pedersen E, et al. Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilation in rats. Stroke 1991; 22:1363-8.
47. Ridderstrale Y, Wistrand PJ, Brechue WF. Membrane-associated CA activity in the eye of the CA II-deficient mouse. Invest Ophthalmol Vis Sci 1994;35:2577-84.
48. Harris A, Arend O, Arend S, et al. Effects of topical dorzolamide on retinal and retrobulbar hemodynamics. Acta Ophthalmol 1996;74:569-72.
49. Flammer J. To what extent are vascular factors involved in the pathogenensis of glaucoma. In: Kaiser HJ, Flammer J, Hendrickson P, eds. Ocular blood flow. Glaucoma meeting, 1995. Basel: Karger, 1996:12-39.